New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.
New Delhi/IBNS: Pharmaceutical company Bharat Biotech's indigenous Coronavirus vaccine-Covaxin-has been taken off the clinical trial mode, which means beneficiaries will not have to sign consent forms before taking the drug.
New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.
New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.
New Delhi/IBNS: The coronavirus vaccines awaiting approval can be cleared soon, India's drug control authority said Thursday.
New Delhi/IBNS: The Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, media reports said.
New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has defended the August 15 launch of COVAXIN, after the scientific community of the country termed the short timeline "risky" and "impossible", a media report said.
Hyderabad/IBNS: India's first homegrown Covid-19 vaccine candidate COVAXIN has received approval from Drug Controller General of India (DCGI) to conduct Phase I and II human trials, said a media report.